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ABSTRACT 
Objective. The first metatarsophalangeal joint (1MTPJ) is frequently affected in gout. The 
aim of this study was to identity ultrasound features of the 1MTPJ in people with gout and 
people with asymptomatic hyperuricaemia compared with normouricaemic controls.  
Methods. Participants with gout (n=23), asymptomatic hyperuricaemia (n=29) and age- and 
sex-matched normouricaemic control participants (n=34) underwent a grey-scale and power 
Doppler ultrasound assessment of bilateral 1MTPJs by a single musculoskeletal radiologist. 
No participants had clinical evidence of joint inflammation at the time of scanning. The 
static images were later read by two musculoskeletal radiologists for the presence of the 
double contour sign, tophus, erosion, effusion, synovial hypertrophy, synovitis and cartilage 
thickness. 
Results. Compared to normouricaemic control participants, participants with gout and 
participants with asymptomatic hyperuricaemia had more frequent double contour sign 
(odds ratio (OR) 3.91, P=0.011 and OR 3.81, P=0.009, respectively). Participants with gout 
also had more erosion (OR 10.13, P=0.001) and synovitis (OR 9.00, P<0.001) and had greater 
tophus and erosion diameters (P=0.035 and P<0.001, respectively).  More severe erosion 
and synovitis grades and a less severe effusion grade were independently associated with 
gout compared with asymptomatic hyperuricaemia (R
2
 = 0.65, p < 0.001).  
Conclusion. Urate deposition, synovitis and bone erosion are common at the 1MTPJ in 
people with gout, even in the absence of flare. Although individuals with asymptomatic 
hyperuricemia lack ultrasound features of inflammation or structural joint changes, they 
demonstrate a similar frequency of urate deposition.  
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SIGNIFICANCE AND INNOVATIONS 
• Ultrasound features of urate deposition, soft tissue inflammation and bone erosion are 
common at the 1MTPJ in people with gout, despite the absence of clinical symptoms of 
acute arthritis.  
• People with asymptomatic hyperuricemia lack features of inflammation and structural 
joint changes on ultrasound, but demonstrate a similar frequency of subclinical urate 
deposition.  
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Gout results from the formation and deposition of monosodium urate (MSU) crystals in 
structures of the musculoskeletal system in the presence of hyperuricaemia [1]. MSU 
crystals have the potential to initiate inflammatory responses resulting in painful episodes 
of arthritis [2, 3]. Although hyperuricaemia is required for the development of symptomatic 
gout, many individuals with hyperuricaemia are clinically asymptomatic [4]. 
Despite a similar level of urate concentration throughout the body, MSU crystal deposition 
and gout-related features have a certain propensity for the first metatarsophalangeal joint 
(1MTPJ). Most people with gout experience acute 1MTPJ arthritis at some point during the 
course of the disease [5]. Furthermore, people with gout report consistent 1MTPJ pain even 
after the resolution of clinical evidence of acute arthritis [6, 7].  The function of the 1MTPJ is 
also impaired in people with gout [8, 9]. It is unclear why gout has a predilection to affect 
the 1MTPJ, but may be associated with biomechanical loading or physical stress during the 
normal gait cycle [10, 11], or the co-occurrence of 1MTPJ osteoarthritis [12, 13]. 
High-resolution ultrasound has recently gained substantial interest in the assessment of 
individuals with gout due to its ability to visualise not only soft tissue inflammation (through 
its power Doppler capability) and joint damage, but also MSU crystal deposition. The 
ultrasound presence of MSU crystals along the surface of articular cartilage (the double 
contour sign) is the most well-recognised ultrasound feature in people with gout and has 
been included in the 2015 ACR/EULAR Gout Classification Criteria [14]. However, the double 
contour sign bears close resemblance to bone interface reflections frequently seen in 
healthy joints, which increases the rate of false-positives [15-17]. The double contour sign 
has also been observed in individuals with asymptomatic hyperuricaemia [18-21]. Despite 
this evidence of crystal deposition in people with asymptomatic hyperuricaemia, very few 
Page 5 of 38
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
Ultrasound of the 1MTPJ in gout and AH 
 
6 
 
studies have systematically assessed for features of soft tissue inflammation and joint 
damage in this population [20-22]. The aim of this study was to identity ultrasound features 
of the 1MTPJ in people with gout and people with asymptomatic hyperuricaemia by 
comparing them with healthy normouricaemic controls.   
 
PATIENTS AND METHODS 
Participants 
Participants with gout were recruited from Auckland District Health Board, New Zealand. All 
participants fulfilled the 1977 preliminary American Rheumatism Association (ARA) 
classification criteria for gout [33]. Participants without gout were recruited from Auckland 
University of Technology (AUT) staff. Participants without gout underwent serum urate 
capillary testing on the day of the study using a Reflotron® Plus (Roche Diagnostics Ltd., New 
Zealand) and were stratified into either the asymptomatic hyperuricaemic group (serum 
urate >6.9mg/dL) or the normouricaemic control group (serum urate <6.9mgl/dL). The three 
groups were age-and sex-matched. Participants were excluded if they were aged under 20 
years; had a history of other inflammatory arthritis; were experiencing acute arthritis at the 
time of the study; had foot and/or ankle surgery in the previous three months; had a history 
of 1MTPJ surgery; or lower limb amputation. Ethical approval for the study was obtained 
from the AUT Ethics Committee (13/100). All participants provided written informed 
consent prior to data collection. Demographic data were obtained from all participants 
including age, gender, ethnicity, body mass index (BMI), current medications and medical 
history. Additionally, gout disease characteristics were documented for participants with 
gout including disease duration, flare history and tophus presence.  
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Ultrasound image acquisition 
The ultrasound examination was performed at the AUT Horizon Scanning Clinic by a single 
experienced musculoskeletal radiologist (BA) who was blinded to all clinical features 
including gout status and serum urate results. A Phillips iU22 diagnostic ultrasound machine 
(Bothell, Washington, USA) with a 10 MHz, 55mm linear array transducer was used. Bilateral 
1MTPJs were scanned with participants positioned supine with legs extended. A water-
based gel was applied to the skin to optimise transducer-skin contact and to provide an 
acoustic interface. The dorsal, medial and plantar aspects of each joint were scanned using a 
multi-planar technique in which transverse and longitudinal planes were imaged. Each joint 
was maximally dorsiflexed and plantarflexed by the radiologist during scanning to ensure 
direct visualisation of the articular surfaces. Each joint was scanned in B-mode grey scale 
and then using power Doppler. Power Doppler involved the use of a standardised pulse 
frequency of 400 to 500 Hz and low wall filters with the gain adjusted to a level just below 
the disappearance of the colour signs under the bony cortex.  
 
Ultrasound image interpretation 
Two musculoskeletal radiologists (BA and RM) who were blinded to all clinical features, 
including gout status and serum urate results, and to each other’s scores, independently 
reviewed the static images for eight ultrasound features: the double contour sign, tophus, 
erosion, effusion, snowstorm appearance, synovial hypertrophy, synovitis and cartilage 
thickness (defined in Supplementary Table 1). In accordance with previous research and the 
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Outcome Measures in Rheumatology group (OMERACT) recommendations, cartilage-related 
features (double contour sign and cartilage thickness) were assessed at the dorsal aspect of 
the 1MTPJ [23]. All remaining ultrasound features were assessed at the dorsal, medial and 
plantar aspects. The double contour sign, tophus and the snowstorm appearance were 
recorded as either present or absent at the 1MTPJ, while erosions, joint effusion, synovial 
hypertrophy and synovitis were graded using a four-grade semi-quantitative scale (grade 
0=absent; grade 1=mild; grade 2=moderate; grade 3=severe) [24, 25]. For erosions, joint 
effusion and synovial hypertrophy the feature was considered present if graded >2 [24]. 
Synovitis was considered present if graded as >1 [25]. Additionally, the largest diameter of 
the largest tophus and erosion in each 1MTPJ was recorded using digital callipers. Thickness 
of the articular cartilage covering the dorsal first metatarsal head was also assessed by 
measuring the longest diameter using digital callipers [26]. 
 
 Statistical Analysis  
Demographic and medical data were described as mean (SD) for continuous data and 
frequency (%) for categorical data. The inter-reader reliability for the presence of each 
ultrasound feature was assessed using Cohen’s kappa (ƙ) in which values of 0 to 0.2 were 
considered poor; 0.2 to 0.4 fair; 0.4 to 0.6 moderate; 0.6 to 0.8 good; and 0.8 to 1.0 
excellent [27].  The inter-reader reliability for cartilage thickness, tophus and erosion 
diameters and the severity grading for erosions, effusion, synovial hypertrophy and synovitis 
was assessed using intra-class correlation coefficients (ICC) which were interpreted using 
the following benchmarks: >0.75 excellent reliability; 0.40 to 0.75 fair to good reliability; and 
<0.40 poor reliability [28]. For the purpose of the inferential analyses, ultrasound feature 
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grades and thickness measures were calculated by taking the mean of the two readers. For 
dichotomous outcome measures (i.e. scored as either present or absent), the feature was 
considered present only if scored as present by both readers. For outcome measures 
assessed at dorsal, medial and plantar sites of the 1MTPJ, the maximum grade and thickness 
measures were used. Binary logistic regression was used to determine between-group 
differences for the presence of the double contour sign, tophus, erosion, effusion, 
snowstorm appearance, synovial hypertrophy and synovitis. Additionally, to determine 
between-group differences in grading of erosions, effusion, synovial hypertrophy and 
synovitis, multinomial regression with cumulative logit link was used. For the continuous 
outcome measures (tophus size, erosion size and cartilage thickness) linear regression 
models were used. All continuous outcomes were reviewed for normality using the residuals 
from a linear model with the participant group as the independent variable. All models 
accounted for repeated measures taken from right and left feet through using a mixed-
models approach in which a participant-specific random effect and participant-nested 
random effect for foot-side were added to the model. This analysis produces results 
identical to an analysis of measures averaged for each foot-side that would allow for a 
between-foot-side correlation and also allows for any reweighting required due to missing 
values. Adjustments for gender, age, ethnicity and BMI, which were entered into each 
model simultaneously, were considered only if their level of observed significance achieved 
at least 10% on the relevant deviance test (Wald test for categorical data or F-test for 
continuous data). Potential covariates were also explored by reviewing box plots of random 
effects by covariate group. Two contrasts were considered: gout vs. control and 
asymptomatic hyperuricaemia vs. control, which were always tested separately. To 
determine which ultrasound features were associated with a diagnosis of gout or 
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asymptomatic hyperuricaemia, a stepwise linear regression was undertaken which included 
tophus presence, double contour sign presence, erosion grade, effusion grade, synovial 
hypertrophy grade and effusion grade. For the purpose of this analysis, ultrasound features 
were considered present in each gout and asymptomatic hyperuricaemic participant if 
present in at least one foot, while for graded variables, the highest grade from both feet was 
used.  All hypothesis tests (excluding covariate testing) were carried out at a 5% level of 
significance against two-sided alternatives. No adjustment for multiplicity was used, but all 
test-statistics, their null distributions and their observed significance levels were reported. 
Data were analysed using IBM SPSS Statistics version 20 and R version 3.2.3.   
 
Sample size calculation 
A sample size calculation was undertaken based on adjusted pooling of data derived from 
studies available at the time of the study conception which had reported the prevalence of 
the double contour sign at the 1MTPJ in people with gout, asymptomatic hyperuricaemia 
and/or healthy controls [7, 19, 21, 29, 30]. From these studies the expected prevalence 
rates of the double contour sign were calculated as 20.6% in gout, 15.4% in asymptomatic 
hyperuricaemia and 0% in healthy controls. As both 1MTPs in each participant were to be 
scanned, the required sample size was divided by two and increased by a design effect 
factor of 1.1 (corresponding to a small intra-class correlation coefficient of approximately 
0.1) to account for association in the probability of the double contour sign within a 
participant. Sample sizes were Familywise Error Rate-adjusted for multiplicity using a 
Bonferroni correction. The calculated sample sizes were 21 with gout, 29 with asymptomatic 
hyperuricaemia and 34 healthy controls. These sizes provide approximately 80% power to 
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detect a difference between asymptomatic hyperuricaemia and controls and 87% power to 
detect a difference between gout and controls at a Bonferroni-corrected significance level 
of 5% against two-sided alternatives. 
 
RESULTS 
All participants were men with a mean age of 58 years and predominantly of European 
ethnicity (Table 1). Participants with gout and asymptomatic hyperuricaemia had 
significantly higher BMI compared to the controls (p < 0.05). Participants with gout had a 
mean (SD) disease duration of 18 (11) years. Eighty-three percent had a history of 1MTPJ 
acute arthritis and 26% had clinical evidence of 1MTPJ tophi. Six (26%) of participants with 
gout were crystal-proven, with the remaining (n = 17, 74%) fulfilling the ARA clinical criteria. 
Inter-reader reliability was moderate for the presence of the double contour sign, tophi, 
erosion, synovial hypertrophy and effusion, and good for synovitis (Table 2). The inter-
reader reliability for the grading of features was fair to good for erosion, synovial 
hypertrophy and effusion and excellent for synovitis. Inter-reader reliability for tophus 
diameter and cartilage thickness was excellent and for erosion diameter was fair to good. 
The descriptive statistics for the sonographic features used in the inferential analyses are 
displayed in Supplementary Table 2. The double contour sign was the most common 
ultrasound feature of urate deposition and was present in a similar number of 1MTPJs in 
both gout (n=17, 37%) and asymptomatic hyperuricaemia groups (n=21, 36%). However, 
only the gout group displayed tophus at the 1MTPJ (n=6, 13%). Synovitis was most common 
in the gout group (n=20, 44%) compared to the control (n=5, 7%) and asymptomatic 
Page 11 of 38
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
Ultrasound of the 1MTPJ in gout and AH 
 
12 
 
hyperuricaemic groups (n=2, 3%).  However, joint effusion was observed more frequently in 
the asymptomatic hyperuricaemic group (n=13, 22%) compared to the gout group (n=4, 
9%). Synovial hypertrophy was less commonly observed and seen in only 2% to 11% of 
joints. Bone erosion was present in 15 (33%) 1MTPs in the gout group and in only 2 (3%) and 
1 (2%) of the control and asymptomatic hyperuricaemic groups, respectively. Cartilage 
thickness was similar across all groups. Supplementary Tables 3 to 5 show the descriptive 
statistics for ultrasound features present at each of the dorsal, medial and plantar aspects of 
the 1MTPJ, respectively. The snowstorm appearance was absent in all participants so was 
excluded from the inferential analysis.  
The distribution of residuals from the linear models for all continuous outcome measures 
demonstrated sufficient normality to carry out parametric testing. All final models were un-
adjusted for covariates which did not achieve significance. The overall presence of 
ultrasound features at the 1MTP demonstrated significant between-group differences 
(Table 3). Compared to controls, both participants with gout and with asymptomatic 
hyperuricaemia had a greater odds of having the double contour sign (OR 3.9; P=0.011, OR 
3.8; P=0.009, respectively). Compared to controls, participants with gout also had an 
increased odds of having 1MTPJ erosions (OR 10.13; P=0.001) and synovitis (OR 9.0; 
P<0.001).  Participants with gout also had a non-significant trend towards an increased odds 
of having 1MTPJ tophus compared to controls (OR 5.08; P=0.057). No significant differences 
were observed for the presence of effusion or synovial hypertrophy between the groups.  
Between-group differences were observed for the grading of ultrasound features at the 
1MTPJ (Table 4). Compared to controls, participants with gout had a greater odds of having 
more severe erosions (OR 101.80; P<0.001), more severe synovial hypertrophy (OR 11.73; 
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P=0.002) and more severe synovitis (OR 47.51; P=0.002). Compared to controls, participants 
with asymptomatic hyperuricaemia had a greater odds of having more severe effusion (OR 
3.08; P=0.046). Compared to controls, participants with gout demonstrated significantly 
greater tophus diameter (P=0.035) and erosion diameter (P<0.001) (Table 5).   
Using stepwise linear regression analysis, a more severe erosion and synovitis grade and a 
less severe effusion grade were independently associated with gout compared with 
asymptomatic hyperuricaemia (model R2=0.65, p<0.001) (Table 6).  
 
DISCUSSION 
This study has shown that ultrasound features of urate deposition, soft tissue inflammation 
and bone damage at the 1MPTJ are present in people with gout despite the absence of 
clinical symptoms of acute arthritis. In contrast, despite a similar frequency of subclinical 
urate deposition at the 1MTPJ, individuals with asymptomatic hyperuricemia do not 
demonstrate features of inflammation or bone erosion on ultrasound. However, they did 
display a similar frequency of urate deposition at the 1MTPJ. 
This study has shown that the double contour sign is significantly more frequent in those 
with gout. Thirty-seven percent of participants with asymptomatic hyperuricaemia in the 
current study also demonstrated the double contour sign on ultrasound which is consistent 
with existing research [18-21] and emphasises the extent of subclinical crystal deposition in 
individuals with asymptomatic hyperuricaemia.  
The frequency of the double contour sign in the patients with gout was similar to those with 
asymptomatic hyperuricaemia (37% vs. 36%). Although 74% of participants with gout had 
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clinically-evident tophi and 63% reported recent episodes of acute arthritis, the relatively 
low frequency of the double contour sign may reflect the use of urate lowering therapy and 
the mean serum urate level below the treatment target (< 6 mg/dl). Sonographic evidence 
of urate deposition including both the double contour sign and tophus have been reported 
to decrease or disappear following urate lowering therapy [31, 32]. This may also explain 
the lower frequency of tophus (13%) at the 1MTP in our participants with gout compared to 
previous sonographic investigations which have observed a tophus frequency of 50% to 100% 
at the 1MTP [7, 10, 30-35]. 
In the current study, both tophi and bone erosion were noted more frequently at the medial 
metatarsal head (Supplementary Tables 3 to 5). This erosion pattern is consistent with 
previous studies in which 46% to 92% of observed 1MTP erosions were located on the 
medial metatarsal head [7, 36]. This distribution of tophaceous material reflects the strong 
association between the urate crystal and inflammatory soft tissue components of tophi and 
the presence of bone erosions [37-39].  
Our multiple regression analysis suggests that features other than crystal deposition, 
specifically synovitis and bone erosion, may be useful in differentiating gout from 
asymptomatic hyperuricaemia. The greater frequency and increased severity of synovitis in 
participants with gout (who did not have a gout flare at the time of scanning) suggests that 
gout is a disease of chronic inflammation with a persistent subclinical immune response to 
MSU crystals. Individuals with asymptomatic hyperuricaemia, despite demonstrating similar 
frequency of double contour sign at the 1MTPJ, did not exhibit features of synovitis, 
indicating that the tissue response to MSU crystals in gout is not present in those with 
asymptomatic hyperuricaemia. Our data are consistent with recent imaging studies using 
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both ultrasound and MRI which have reported synovial pannus in 87.5% [40] and synovitis in 
up to 95.8% of people with intercritical gout [41, 42]. Together, these data suggest that 
synovial inflammation is a common finding in patients with gout, even in the absence of 
clinically apparent flares. The relevance of synovial inflammation in predicting future gout 
flares or joint damage is currently unknown. 
Moderate inter-reader reliability was demonstrated in this study for the presence of the 
double contour sign (ƙ = 0.49) which is in contrast to the majority of previous ultrasound 
studies which report good to excellent reliability (ƙ = 0.68 to 0.98) [18, 30, 43-47]. There are 
several factors which may have influenced the reliability of this sign in the current study. 
Firstly, there is a strong resemblance between the double contour sign and cartilage 
interface sign, with the latter often appearing as a result of increased reflectivity at a 90° 
insonation angle, and the former appearing dependant of the insonation angle. Dynamic 
conformation of the double contour sign could not be performed in the current study as the 
presence of the sonographic features were assessed from static images. Secondly, the 
presence of even minimal joint effusion, which was observed frequently in 1MTPJs in the 
current study, can also accentuate the cartilage interface sign due to enhanced reflectivity 
[15]. Thin or damaged cartilage, such as that seen in osteoarthritis (which is prevalent at the 
1MTPJ) [48], may also impair visualisation of the double contour sign [15]. Importantly, in 
our analyses, all features were considered present only if both musculoskeletal radiologists 
reported the feature as present.  
The findings from this study should be considered in light of several limitations. Firstly, 
participants with gout were recruited from secondary-care clinics and had longstanding 
disease, and it is possible that the findings are not generalizable to people with gout treated 
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in primary-care. It should also be noted that this study was undertaken prior to publication 
of the recent 2015 ACR/EULAR classification criteria for gout [14] and the majority of the 
participants with gout had not undergone microscopic assessment for urate crystals and 
were classified based on clinical criteria which has limited specificity [49]. Also, the 
participants with normouricaemia were included based on a single measure of serum urate 
on the day of the study. Although major diurnal variation in urate is uncommon [50], mild 
variation in serum urate can occur. It is possible that the single measurement may have 
misclassified some participants with asymptomatic hyperuricaemia and normouricaemia 
groups, and that multiple testing of serum urate over a longer time period would have 
increased the accuracy of this inclusion criterion. Furthermore, participants with 
asymptomatic hyperuricemia had relatively low hyperuricaemia and it is unclear whether 
the results would have differed if they had higher urate levels. The cross-sectional nature of 
study does not allow us to determine the prognostic relevance of asymptomatic ultrasound 
findings. Future studies may consider the relationship between ultrasound features 
suggestive of gouty arthritis and clinically-assessed structural and functional characteristics 
of the 1MTPJ. A longitudinal follow-up to determine the predictive appeal of ultrasound in 
the development of symptomatic gout in those with asymptomatic hyperuricaemia may also 
be of value. 
In conclusion, this study has shown that compared to normouricaemic controls, ultrasound 
features of urate deposition, soft tissue inflammation and bone erosion are common at the 
1MTPJ in people with gout, despite the absence of clinical symptoms of acute arthritis. 
Furthermore, although individuals with asymptomatic hyperuricemia lack features of 
inflammation or structural joint changes on ultrasound, they demonstrate a similar 
frequency of subclinical urate deposition. Features other than crystal deposition, specifically 
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synovitis and bone erosion, may be useful in differentiating gout from asymptomatic 
hyperuricaemia. These data support the concept that gout is a disease of chronic 
inflammation with a persistent subclinical immune response to the presence of MSU crystals 
within joints.  
 
ACKNOWLEDGEMENTS  
None. 
  
Page 17 of 38
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
Ultrasound of the 1MTPJ in gout and AH 
 
18 
 
REFERENCES 
[1] Loeb JN. The influence of temperature on the solubility of monosodium urate. 
Arthritis Rheum 1972; 15: 189-92. 
[2] Martinon F. Gout-associated uric acid crystals activate the NALP3 inflammasome. 
Nature 2006; 440: 237-41. 
[3] Dalbeth N, Pool B, Gamble GD, Smith T, Callon KE, McQueen FM, et al. Cellular 
characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum 2010; 
62: 1549-56. 
[4] Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and 
consequences in the Normative Aging Study. Am J Med 1987; 82: 421-6. 
[5] Stewart S, Dalbeth N, Vandal AC, Rome K. The first metatarsophalangeal joint in 
gout: a systematic review and meta-analysis. BMC Musculoskelet Disord 2016; 17: 
69-83. 
[6] Roddy E, Muller S, Rome K, Chandratre P, Hider S, Richardson J, et al. Foot 
problems in people with gout in primary care: baseline findings from a prospective 
cohort study. J Foot Ankle Res 2015; 8: 30-41. 
[7] Wright SA, Filippucci E, McVeigh C, Grey A, McCarron M, Grassi W, et al. High-
resolution ultrasonography of the first metatarsal phalangeal joint in gout: a 
controlled study. Ann Rheum Dis 2007; 66: 859-64. 
[8] Kim YS, Park EH, Lee HJ, Koh YG. First metatarsophalangeal joint arthrodesis for the 
treatment of tophaceous gouty arthritis. Orthopedics 2014; 37: e141-7. 
[9] Wang CC, Lien SB, Huang GS, Pan RY, Shen HC, Kuo CL, et al. Arthroscopic 
elimination of monosodium urate deposition of the first metatarsophalangeal joint 
reduces the recurrence of gout. Arthroscopy 2009; 25: 153-8. 
Page 18 of 38
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
Ultrasound of the 1MTPJ in gout and AH 
 
19 
 
[10] Thiele RG, Schlesinger N. Diagnosis of gout by ultrasound. Rheumatology (Oxford) 
2007; 46: 1116-21. 
[11] Dalbeth N, Deacon M, Gamble GD, Mithraratne K, Fernandez J. Relationship between 
tissue stress during gait in healthy volunteers and patterns of urate deposition and bone 
erosion in gout: a biomechanical computational modelling study. RMD Open 2015; 
1:e000101. 
[12] Kawenoki-Minc E, Eyman E, Leo W, Weryńska-Przybylska J. Osteoarthrosis and 
spondylosis in gouty patients. Analysis of 262 cases of gout. Reumatologia 1974; 
12: 267-7. 
[13] Roddy E, Zhang W, Doherty M. Are joints affected by gout also affected by 
osteoarthritis? Ann Rheum Dis 2007; 66: 1374-7. 
[14] Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, et al. 2015 
Gout Classification Criteria: An American College of Rheumatology/European 
League Against Rheumatism collaborative initiative. Arthritis Rheumatol 2015; 67: 
2557-68. 
[15] Ottaviani S, Bardin T, Richette P. Usefulness of ultrasonography for gout. Joint Bone 
Spine 2012; 79: 441-5. 
[16] Singh JA, Dalbeth N. Is the double contour sign specific for gout? Or only for crystal 
arthritis? J Rheumatol 2015; 42: 353-4. 
[17] Russell E, Checa A. Potential pitfalls in the diagnosis of crystal-induced arthritis and 
in the sonographic measurement of hyaline cartilage due to the presence of joint 
effusion. J Clin Rheumatol 2013; 19: 98-100. 
Page 19 of 38
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
Ultrasound of the 1MTPJ in gout and AH 
 
20 
 
[18] De Miguel E, Puig JG, Castillo C, Peiteado D, Torres RJ, Martín-Mola E. Diagnosis of 
gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study. Ann 
Rheum Dis 2012; 71: 157-8. 
[19] Howard RG, Pillinger MH, Gyftopoulos S, Thiele RG, Swearingen CJ, Samuels J. 
Reproducibility of musculoskeletal ultrasound for determining monosodium urate 
deposition: concordance between readers. Arthritis Care Res 2011; 63: 1456-62. 
[20] Reuss-Borst MA, Pape CA, Tausche AK. Hidden gout- Ultrasound findings in patients 
with musculo-skeletal problems and hyperuricemia. Springerplus 2014; 3: 592-8. 
[21] Pineda C, Amezcua-Guerra LM, Solano C, Rodriguez-Henríquez P, Hernández-Díaz C, 
Vargas A, et al. Joint and tendon subclinical involvement suggestive of gouty 
arthritis in asymptomatic hyperuricemia: an ultrasound controlled study. Arthritis 
Res Ther 2011; 13: R4-10. 
[22] Puig JG, de Miguel E, Castillo MC, Rocha AL, Martínez MA, Torres RJ. Asymptomatic 
hyperuricemia: impact of ultrasonography. Nucleosides Nucleotides Nucleic Acids 
2008; 27: 592-5. 
[23] Terslev L, Gutierrez M, Schmidt WA, Keen HI, Filippucci E, Kane D, et al. Ultrasound 
as an Outcome Measure in Gout. A Validation Process by the OMERACT Ultrasound 
Working Group. J Rheumatol 2015; 42: 2177-81. 
[24] Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS, Østergaard M. 
Interobserver agreement in ultrasonography of the finger and toe joints in 
rheumatoid arthritis. Arthritis Rheum 2003; 48: 955-62. 
[25] Szkudlarek M, Court-Payen M, Strandberg C, Klarlund M, Klausen T, Ostergaard M. 
Power Doppler ultrasonography for assessment of synovitis in the 
Page 20 of 38
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
Ultrasound of the 1MTPJ in gout and AH 
 
21 
 
metacarpophalangeal joints of patients with rheumatoid arthritis: a comparison 
with dynamic magnetic resonance imaging. Arthritis Rheum 2001; 44: 2018-23. 
[26] Mandl P, Supp G, Baksa G, Radner H, Studenic P, Gyebnar J, et al. Relationship 
between radiographic joint space narrowing, sonographic cartialge thickness and 
anatomy in rheumatoid arthritis and control joints. Ann Rheum Dis 2014; 74: 2022-
7. 
[27] Landis JR, Koch GG. The measurement of observer agreement for categorical data. 
Biometrics 1977; 33: 159-74. 
[28] Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psycho 
Bull 1979;  86: 420-8. 
[29] Ottaviani S, Allard A, Bardin T, Richette P. An exploratory ultrasound study of early 
gout. Clin Exp Rheumatol 2011; 29: 816-21. 
[30] Naredo E, Uson J, Jiménez-Palop M, Martínez A, Vicente E, Brito E, et al. 
Ultrasound-detected musculoskeletal urate crystal deposition: which joints and 
what findings should be assessed for diagnosing gout? Ann Rheum Dis 2013; 73: 
1522-8. 
[31] Thiele RG, Schlesinger N. Ultrasonography shows disappearance of monosodium 
urate crystal deposition on hyaline cartilage after sustained normouricaemia is 
achieved. Rheumatol Int 2010; 30: 495-503. 
[32] Ottaviani S, Gill G, Aubrun A, Palazzo E, Meyer O, Dieudé P. Ultrasound in gout: A 
useful tool for following urate-lowering therapy. Joint Bone Spine 2015; 82: 42-4. 
[33] Kang MH, Moon KW, Jeon YH, Cho SW: Sonography of the first 
metatarsophalangeal joint and sonographically guided intraarticular injection of 
corticosteroid in acute gout attack. J Clin Ultrasound 2015; 43: 179-86. 
Page 21 of 38
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
Ultrasound of the 1MTPJ in gout and AH 
 
22 
 
[34] Eliseev M, Zhelyabina O, Vladimirov S, Severinova M, Nasonov E. Ultrasonography 
signs of MSU urate deposition in patients with hyperuricemia and early diagnosis of 
gout. Ann Rheum Dis 2016; 75: 1183. 
[35] Norkuviene E, Petraitis M, Apanaviciene I, Virviciute D, Baranauskaite A. Ultrasound 
in gout: which joints should be evaluated concerning differences between the early 
and late gout? Ann Rheum Dis 2016; 75: 372. 
[36] Ventura-Ríos L, Hernández-Díaz C, Sanchez-Bringas G, Madrigal-Santillán E, 
Morales-González JA, Pineda C. A descriptive, cross-sectional study characterizing 
bone erosions in rheumatoid arthritis and gout by ultrasound. Clin Rheumatol 2016; 
ahead of print. 
[37] Sapsford M, Gamble G, Aati O, Knight J, Horne A, Doyle A, Dalbeth N. Bone erosion 
in gout: Relationship with tophus urate and soft tissue volumes: A conventional and 
dual energy CT study. Arthritis Rheumatol 2015; 67: 1. 
[38] Dalbeth N, Clark B, Gregory K, Gamble G, Sheehan T, Doyle A, McQueen FM. 
Mechanisms of bone erosion in gout: a quantitative analysis using plain 
radiography and computed tomography. Ann Rheum Dis 2009; 68: 1290-5. 
[39] McQueen FM, Doyle A, Reeves Q, Gao A, Tsai A, Gamble GD, Curteis B, Williams M, 
Dalbeth N. Bone erosions in patients with chronic gouty arthropathy are associated 
with tophi but not bone oedema or synovitis: new insights from a 3 T MRI study. 
Rheumatol 2014; 53: 95-103. 
[40] Carter JD, Patelli M, Anderson SR, Prakash N, Rodriquez EJ, Bateman H, et al . An 
MRI assessment of chronic synovial-based inflammation in gout and its correlation 
with serum urate levels. Clin Rheumatol 2015; 34: 345-51. 
Page 22 of 38
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
Ultrasound of the 1MTPJ in gout and AH 
 
23 
 
[41] Schueller-Weidekamm C, Schueller G, Aringer M, Weber M, Kainberger F. Impact of 
sonography in gouty arthritis: comparison with conventional radiography, clinical 
examination, and laboratory findings. Eur J Radiol 2007; 62: 437-43. 
[42] Peiteado D, Villalba A, Martin-Mola E, de Miguel E. Reduction but not 
disappearance of Doppler signal after two years of treatment for gout. Do we need 
a more intensive treatment? Clin Exp Rheumatol 2015; 33: 385-90. 
[43] Peiteado D, De Miguel E, Villalba A, Ordóñez MC, Castillo C, Martín-Mola E. Value of 
a short four-joint ultrasound test for gout diagnosis: a pilot study. Clin Exp 
Rheumatol 2012; 30: 830-7. 
[44] Lai K-L, Chiu Y-M. Role of ultrasonography in diagnosing gouty arthritis. J Med 
Ultrasound 2011; 19: 7-13. 
[45] Ottaviani S, Richette P, Allard A, Ora J, Bardin T. Ultrasonography in gout: a case-
control study. Clinical Exp Rheumatol 2012; 30: 499-504. 
[46] Filippucci E, Riveros MG, Georgescu D, Salaffi F, Grassi W. Hyaline cartilage 
involvement in patients with gout and calcium pyrophosphate deposition disease. 
An ultrasound study. Osteoarthritis Cartilage 2009; 17: 178-81. 
[47] Gutierrez M, Schmidt WA, Thiele RG, Keen HI, Kaeley GS, Naredo E, et al. 
International Consensus for ultrasound lesions in gout: results of Delphi process 
and web-reliability exercise. Rheumatology 2015; 1797-805. 
[48] Roddy E, Thomas MJ, Marshall M, Rathod T, Myers H, Menz HB, et al. The 
population prevalence of symptomatic radiographic foot osteoarthritis in 
community dwelling older adults: cross-sectional findings from the Clinical 
Assessment Study of the Foot. Ann Rheum Dis 2013; 74: 156-63. 
Page 23 of 38
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
Ultrasound of the 1MTPJ in gout and AH 
 
24 
 
[49] Malik A, Schumacher HR, Dinnella JE, Clayburne GM. Clinical diagnostic criteria for 
gout: comparison with the gold standard of synovial fluid crystal analysis. J Clin 
Rheumatol 2009; 15: 22-4. 
[50] Stamp LK, Zhu X, Dalbeth N, Jordon S, Edwards NL, Taylor W. Serum urate as a 
soluble biomarker in chronic gout-evidence that serum urate fulfills the OMERACT 
validation criteria for soluble biomarkers. Semin Arthritis Rheum 2011; 40: 483-500. 
  
Page 24 of 38
John Wiley & Sons, Inc.
Arthritis Care & Research
This article is protected by copyright. All rights reserved.
Ultrasound of the 1MTPJ in gout and AH 
 
25 
 
TABLES 
 
Table 1. Demographic characteristics.  
Variable Control Gout Asymptomatic 
hyperuricaemia 
N 34 23 29 
Gender, male, n (%) 34 (100) 23 (100) 29 (100) 
Age, years 58 (14) 58 (14) 58 (19) 
Ethnicity, n (%) 
European 30 (88) 
Maori 1 (3) 
Pacific 0 (0) 
Asian 3 (9) 
European 14 
(61) 
Maori 1 (4) 
Pacific 4 (17) 
Asian 4 (17) 
European 24 (83) 
Maori 0 (0) 
Pacific 3 (10) 
Asian 2 (7) 
BMI, kg/m2 25.0 (2.9) 30.8 (3.8)† 29.3 (5.9)† 
Diuretic use, n (%) 4 (12) 3 (13) 7 (24) 
NSAID use, n (%) 7 (21) 14 (61)
†
 11 (38) 
Prednisone use, n (%) 0 (0) 5 (22) 0 (0) 
Hypertension, n (%) 9 (26) 16 (70)† 16 (55)† 
Cardiovascular disease, n (%) 1 (3) 6 (26)
†
 5 (17) 
Diabetes, n (%) 2 (6) 4 (17) 1 (3) 
Serum urate, mg/dl 5.4 (1.0) 5.9 (1.7) 7.7 (0.8)† 
Serum urate, mg/dl, range 3.4 – 6.7 4.0 – 10.6 6.9 – 10.6 
Highest ever serum urate, - 10.1 (2.2) - 
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mg/dl 
1MTP tenderness, n (%) 1 (3) 6 (26) 1 (3) 
1MTP swelling, n (%) 0 (0) 1 (4) 0 (0) 
Tender joint count (/68) 0.6 (1.2) 2.6 (6.4)† 1.5 (1.9) 
Swollen joint count (/66) 0.0 (0.0) 0.9 (1.2)
†
 0.2 (0.7) 
Crystal-proven gout, n (%) - 6 (26) - 
Disease duration, years - 18 (11) - 
Age of onset, years - 40 (19) - 
Acute flare in preceding 3 
months, n (%) 
- 15 (63) - 
Number of acute flares in 
preceding 3 months 
- 1.4 (1.4) - 
1MTP flares in preceding 3 
months, n (%) 
- 6 (26) - 
History of 1MTP flares, n (%) - 19 (83) - 
Presence of subcutaneous 
tophi, n (%) 
- 17 (74) - 
Presence of 1MTP tophi, n (%) - 6 (26) - 
Colchicine use, n (%) - 13 (57) - 
Urate lowering therapy‡, n (%) - 22 (96) - 
Allopurinol use, n (%) - 18 (79) - 
Probenecid use, n (%) - 3 (13) - 
Benzbromarone use, n (%) - 2 (9) - 
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Table 2. Inter-reader reliability of ultrasound features at the 1MTPJ† 
 N (%) Percent 
agreement 
ƙ 
95% CI for ƙ 
Reader 1 Reader 2 Lower Upper 
Double contour sign 
presence
 
87 (51) 51 (30) 74.4% 0.49 0.37 0.61 
Tophus presence 15 (9) 7 (4) 94.2% 0.52 0.26 0.78 
Erosion presence 10 (6) 19 (11) 92.4% 0.52 0.29 0.74 
Effusion presence 31 (18) 21 (12) 84.9% 0.42 0.23 0.60 
Snowstorm presence 2 (1) 0 (0) 98.8% - - - 
Synovial hypertrophy 
presence 
15 (9) 14 (8) 93.6% 0.59 0.36 0.81 
Synovitis presence 22 (13) 21 (12) 92.4% 0.66 0.48 0.83 
 Mean (SD)  
ICC3,1 
95% CI for ICC 
 Reader 1 Reader 2  Lower Upper 
Tophus diameter, mm  0.8 (3.3) 0.5 (3.1)  0.86 0.81 0.89 
Erosion grade 0.4 (0.6) 0.4 (0.7)  0.72 0.64 0.79 
Erosion diameter, mm 1.2 (2.3) 0.7 (1.7)  0.60 0.50 0.69 
Effusion grade 0.8 (0.8) 0.5 (0.7)  0.50 0.38 0.60 
Febuxostat use, n (%) - 2 (9) - 
Values presented as mean (SD) unless otherwise indicated. †Significantly different from 
control group (p < 0.05). ‡3 patients were taking >1 urate lowering agent. BMI = body 
mass index; NSAID = non-steroidal anti-inflammatory drugs. 
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Synovial hypertrophy grade 0.6 (0.7) 0.2 (0.7)  0.53 0.41 0.63 
Synovitis grade 0.2 (0.5) 0.2 (0.5)  0.81 0.75 0.85 
Cartilage thickness, mm† 0.64 (0.20) 0.64 (0.19)  0.81 0.75 0.86 
†
n=172 joints. ƙ = kappa statistic; ICC = Intra-class Correlation Coefficient; CI = Confidence 
Interval. 
 
Table 3. Odds ratios for the presence of ultrasound features at the 1MTPJ 
 
N (%) Odds Ratio
† 
95% CI for OR 
p 
Lower Upper 
Double Contour 
Sign 
Control 9 (13%)     
Gout 17 (37%) 3.91 1.37 11.20 0.011 
AH 21 (36%) 3.81 1.41 10.36 0.009 
Tophus 
Control 0 (0%)     
Gout 6 (13%) 5.08 0.96 27.08 0.057 
AH 0 (0%) 1.00 0.12 8.26 1.000 
Erosion‡ 
Control 2 (3%)     
Gout 15 (33%) 10.13 2.75 37.28 0.001 
AH 1 (2%) 0.83 0.14 4.88 0.828 
Effusion
‡
 
Control 12 (18%)     
Gout 4 (9%) 0.45 0.13  1.61 0.217 
AH 13 (22%) 1.34 0.51 3.54 0.548 
Synovial 
hypertrophy‡ 
Control 0 (0%)     
Gout 1 (2%) 3.25 0.67 15.73 0.142 
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AH 2 (3%) 1.72 0.32 9.13 0.523 
Synovitis‡ 
Control 5 (7%)     
Gout 20 (44%) 9.00 3.10 26.08 <0.001 
AH 2 (3%) 0.60 0.14 2.69 0.505 
†Reference category = control group; All odds ratios are presented unadjusted for 
covariates. 
‡
The overall presence of erosion, effusion and synovial hypertrophy is based 
on a grade of > 2; the overall presence of synovitis is based on a grade of > 1. CI = 
Confidence Interval; OR = Odds Ratio. 
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Table 4. Odds ratios for grading of ultrasound features at the 1MTPJ 
 
Odds Ratio
† 
95% CI for OR 
p 
Lower Upper 
Erosion grade
 
Gout 101.80 16.56 625.68 <0.001 
AH 1.81 0.49 6.68 0.371 
Effusion grade 
Gout 0.51 0.15 1.65 0.260 
AH 3.08 1.02 9.31 0.046 
Synovial hypertrophy 
grade
 
Gout 11.73 2.48 55.48 0.002 
AH 1.54 0.36 6.52 0.558 
Synovitis grade
 
Gout 47.51 4.29 526.07 0.002 
AH 0.46 0.05 4.60 0.511 
†Reference category = control group. The odds ratio represents the odds of the diagnostic 
group moving up one grade, compared to the control group moving up one grade. All 
odds ratios are presented unadjusted for covariates. CI = Confidence Interval; OR = Odds 
Ratio 
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Table 5. Linear regression for size and thickness of ultrasound features at the 1MTPJ 
 Least-squares 
mean
† 
Diff. 
95% CI for Diff. 
p 
Lower Upper 
Tophus diameter, mm 
Control 0.00     
Gout 1.68 1.68 0.12 0.32 0.035 
AH 0.00 0.00 -1.46 1.46 1.000 
Erosion diameter, mm 
Control 0.05     
Gout 1.55 1.50 0.84 2.16 <0.001 
AH 0.05 -0.00 -0.62 0.61 0.989 
Cartilage thickness 
average, mm 
Control 0.66     
Gout 0.64 -0.02 -0.08 0.03 0.364 
AH 0.62 -0.01 -0.06 0.04 0.773 
†Mean estimates are presented unadjusted for covariates. Diff. = Difference in least-
squares mean; CI = Confidence Interval. 
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Table 6. Stepwise linear regression analysis of ultrasound features independently associated 
with gout compared with asymptomatic hyperuricaemia 
Variables 
included 
Standardised 
β 
Partial R
2
 
change 
p Model Variables excluded  
Erosion grade 
Synovitis grade 
Effusion grade 
0.59 
0.39 
-0.26 
0.49 
0.16 
0.07 
< 0.001 
< 0.001 
0.002 
R2 = 0.65; 
F = 32.22; 
P < 0.001 
Tophus; double 
contour sign; 
synovial 
hypertrophy grade. 
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